IRONWOOD PHARMACEUTICALS INC - Class A common stock, $0.001 par value (IRWD)

CUSIP: 46333X108

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class
Equity / Class A common stock, $0.001 par value
Shares outstanding
162,690,355
Total 13F shares
167,942,496
Share change
-1,605,982
Total reported value
$2,080,711,382
Put/Call ratio
5.1%
Price per share
$12.39
Number of holders
248
Value change
-$11,969,237
Number of buys
121
Number of sells
106

Quarterly Holders Quick Answers

What is CUSIP 46333X108?
CUSIP 46333X108 identifies IRWD - IRONWOOD PHARMACEUTICALS INC - Class A common stock, $0.001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of IRONWOOD PHARMACEUTICALS INC - Class A common stock, $0.001 par value (IRWD) as of Q4 2022

As of 31 Dec 2022, IRONWOOD PHARMACEUTICALS INC - Class A common stock, $0.001 par value (IRWD) was held by 248 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 167,942,496 shares. The largest 10 holders included BlackRock Inc., Sarissa Capital Management LP, VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, STATE STREET CORP, LSV ASSET MANAGEMENT, CREDIT SUISSE AG/, RENAISSANCE TECHNOLOGIES LLC, BROWN CAPITAL MANAGEMENT LLC, and MILLENNIUM MANAGEMENT LLC. This page lists 248 institutional shareholders reporting positions in this security for the Q4 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.